Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder

Research output: Patent

Standard

Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder. / Bøgesø, Klaus P (Inventor); Juhl, K (Inventor); Zhong, H (Inventor); Løland, Claus Juul (Inventor).

Patent No.: WO2013110313-A1.

Research output: Patent

Harvard

Bøgesø, KP, Juhl, K, Zhong, H & Løland, CJ, Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder, Patent No. WO2013110313-A1.

APA

Bøgesø, K. P., Juhl, K., Zhong, H., & Løland, C. J. (2013). Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder. (Patent No. WO2013110313-A1).

Vancouver

Bøgesø KP, Juhl K, Zhong H, Løland CJ, inventors. Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder. WO2013110313-A1. 2013.

Author

Bøgesø, Klaus P (Inventor) ; Juhl, K (Inventor) ; Zhong, H (Inventor) ; Løland, Claus Juul (Inventor). / Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder. Patent No.: WO2013110313-A1.

Bibtex

@misc{5ff565e95380463184f5e2cd50ccf4b8,
title = "Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder",
abstract = "NOVELTY - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound (I) in combination with serotonin reuptake inhibitor, is used.USE - For treatment of CNS disease (claimed) including depression, anxiety, bipolar disorder, obsessive compulsory disorder, post traumatic stress disorder and social anxiety disorder.ADVANTAGE - The compound (I) potentiates the effect of compound that inhibits serotonin reuptake; and selectively modulates the allosteric site at the serotonin transporter.DETAILED DESCRIPTION - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound of formula (I) in combination with serotonin reuptake inhibitor, is used.",
author = "B{\o}ges{\o}, {Klaus P} and K Juhl and H Zhong and L{\o}land, {Claus Juul}",
year = "2013",
language = "English",
type = "Patent",
note = "WO2013110313-A1; C07D-307/79",

}

RIS

TY - PAT

T1 - Use of dihydro-isobenzofuran in combination with serotonin reuptake inhibitors for CNS disease e.g. depression, anxiety, bipolar disorder, obsessive compulsory disorder

AU - Bøgesø, Klaus P

AU - Juhl, K

AU - Zhong, H

AU - Løland, Claus Juul

PY - 2013

Y1 - 2013

N2 - NOVELTY - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound (I) in combination with serotonin reuptake inhibitor, is used.USE - For treatment of CNS disease (claimed) including depression, anxiety, bipolar disorder, obsessive compulsory disorder, post traumatic stress disorder and social anxiety disorder.ADVANTAGE - The compound (I) potentiates the effect of compound that inhibits serotonin reuptake; and selectively modulates the allosteric site at the serotonin transporter.DETAILED DESCRIPTION - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound of formula (I) in combination with serotonin reuptake inhibitor, is used.

AB - NOVELTY - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound (I) in combination with serotonin reuptake inhibitor, is used.USE - For treatment of CNS disease (claimed) including depression, anxiety, bipolar disorder, obsessive compulsory disorder, post traumatic stress disorder and social anxiety disorder.ADVANTAGE - The compound (I) potentiates the effect of compound that inhibits serotonin reuptake; and selectively modulates the allosteric site at the serotonin transporter.DETAILED DESCRIPTION - For treatment of a CNS disease in a patient, dihydro-isobenzofuran compound of formula (I) in combination with serotonin reuptake inhibitor, is used.

M3 - Patent

M1 - WO2013110313-A1

ER -

ID: 137375992